Funding for this research was provided by:
Received: 25 January 2022
Accepted: 14 April 2022
First Online: 26 April 2022
: The authors declare no competing interests.
: The study was conducted out after receiving ethical approval from Haramaya University College of Health Science and Medical Sciences Institutional Health Research Ethics Review Committee (IHRERC). This study was conducted in accordance with the Declaration of Helsinki. Each child's parent/guardian has been sufficiently informed of the study's purpose and the importance of their participation by the data collectors and/or the investigator. Written, Informed, voluntary, and signed consent were taken from all parents/guardians and assent were taken from the child before commencing the study. All parents/guardians were consulted about the benefit of the treatment by a pediatrician who works at Jigjiga University Sultan Shiek Hassen Referral Hospital and the drugs were given free of charge.
: Not applicable.
: There were no conflicts of interest.